Conclusions
As evidenced through HIV prevention trials among at-risk populations, adolescents appreciated simplified use and infrequent dosing, minimal or non-existent side effects, assurance of product efficacy, and methods that alleviated worries around forgetting doses. Our study underscores the significance of user-centric options in enhancing long-term adoption and trustworthiness, thus contributing valuable insights for the future development and promotion of HIV prevention products. We also recommend that the social support from appropriate staff will be essential for the uptake and use of new product use. HIV prevention option for women requires leveraging existing social support groups and emphasizing multiple method options for young women. Although injections were most preferred, expanding the availability of daily pills and the vaginal ring can provide adolescents with multiple choices in HIV prevention technologies, understanding that prevention option naïve users need varying options. In conclusion, this study’s findings provide further insights into factors that are key to young women’s preferences of HIV prevention methods. As enthusiasm grows for the development of products, product developers and providers should also be aware of this knowledge to empower young women with tools to better protect their health globally.